Table of Contents
Imagine taking your daily diabetes pill without knowing it might already be under recall. That’s the glimepiride recall Korea officials just announced for a widely used type 2 diabetes drug.
In August 2026, Korea’s Ministry of Food and Drug Safety (MFDS) ordered a recall of a batch of Geulimideu-jeong 2mg (글리미드정2mg), a glimepiride tablet made by Guju Pharm (구주제약), after concerns emerged about possible foreign substance contamination during manufacturing. If you or a family member takes this medication in Korea, the natural next question is simple: is the box in your medicine cabinet part of the recalled batch?
This article covers exactly which batch is affected by the glimepiride recall Korea order, why it happened, and a 3-step process to check whether your own diabetes medication is included. We also explain what to do if you’ve already taken the recalled batch.
Glimepiride Recall Korea: Which Products Are Affected?
Yes, but only one specific lot of Geulimideu-jeong 2mg made by Guju Pharm is affected, not every box of the product. The glimepiride recall Korea authorities issued applies to that single lot only, not the entire product line.
Geulimideu-jeong 2mg is a tablet containing 2mg of glimepiride, used alongside diet and exercise to help control blood sugar in people with type 2 diabetes. It’s typically prescribed once daily, before breakfast.
| Item | Detail |
|---|---|
| Product | Geulimideu-jeong 2mg (글리미드정2mg), glimepiride |
| Manufacturer | Guju Pharm (구주제약) |
| Recalled lot number | 10662601 |
| Expiration date | April 7, 2029 |
| Recall order date | August 13, 2026 |
| Package sizes | 30 tablets/bottle, 300 tablets/bottle |
| Recall type | Voluntary recall (foreign substance contamination concern) |
Only lot number 10662601 is recalled — not every bottle of Geulimideu-jeong 2mg. If your bottle shows a different lot number, it isn’t part of this recall.
Why Was It Recalled? What Does “Foreign Substance Contamination” Mean?
A concern arose that a substance that shouldn’t be in the medication may have entered it during manufacturing.
Foreign substance contamination means an unintended material got mixed into a medication during production or packaging. MFDS classified this as a voluntary recall by the manufacturer, triggered by a contamination “concern” rather than a confirmed, described hazard.
The exact material and how much of it may be present haven’t been disclosed publicly. Recalls like this are often precautionary — pulling stock from circulation before safety is fully confirmed either way.
Since the exact substance and its risk to health haven’t been officially confirmed, don’t assume the worst — but do stop taking the affected lot and watch for any unusual symptoms.
How Can I Check If My Own Diabetes Medication Is Recalled?
Check three things printed on the packaging, in order: product name, manufacturer, and lot number.
If you received loose pills from a pharmacy without the original box, ask your pharmacy directly — that’s the most reliable way to confirm.
✅ Confirm the product name reads “Geulimideu-jeong 2mg (글리미드정2mg)”
✅ Confirm the manufacturer is “Guju Pharm (구주제약)”
✅ Confirm the lot number on the bottle or box is “10662601”
✅ Double-check via MFDS’s Nedrug portal (nedrug.mfds.go.kr) recall notices
If even one of these four doesn’t match, your medication isn’t part of the glimepiride recall Korea. If all four match, it is.
For more on managing diabetes medication in Korea, see our related articles. Visit the Medications & Supplements category (Internal link: recommend replacing with related post after publishing)
What Should I Do If I’ve Already Taken the Recalled Medication?
Stop taking pills from the affected lot, but don’t stop your diabetes treatment on your own — talk to a doctor first. Anyone caught up in the glimepiride recall Korea announced should follow these steps carefully.
Suddenly stopping a diabetes medication can cause blood sugar to spike, so a doctor needs to decide whether you need a replacement prescription.
1) Stop taking pills from lot 10662601 2) Don’t throw the rest away yourself — return them to the pharmacy where you bought them 3) See a doctor or pharmacist before switching medications
If you notice stomach pain, hives, or any symptom that feels out of the ordinary, visit a nearby clinic or hospital. If you’re not enrolled in Korea’s National Health Insurance (건강보험, Korea’s public health insurance system covering most residents), a private clinic visit is still possible but will cost more out of pocket — worth knowing if you’re new to the Korean healthcare system.
Frequently Asked Questions
1. Q. I got loose pills from a pharmacy and don’t know the lot number. How do I check?
A. Ask the pharmacy that dispensed your medication — they can look up the lot number used at the time. Contacting the pharmacy or your clinic directly is the most reliable option.
2. Q. I’ve already taken pills from the recalled lot for a few days. Should I be worried about side effects?
A. MFDS hasn’t disclosed the specific substance or its health risk. If you haven’t had unusual symptoms like stomach pain or an allergic reaction, there’s no need to panic — but see a doctor if anything feels off.
3. Q. Can I just stop taking my diabetes medication?
A. Stopping on your own isn’t recommended, since blood sugar can spike suddenly. Stop the recalled lot, but let a doctor decide whether you need a replacement prescription.
4. Q. Are other glimepiride medications from different manufacturers also recalled?
A. No. The glimepiride recall Korea issued is limited to one specific lot (10662601) from Guju Pharm. Glimepiride products from other manufacturers, or other lots from Guju Pharm, aren’t affected.
5. Q. Where do I return recalled medication?
A. Start with the pharmacy where you bought it. If needed, Guju Pharm or the MFDS Nedrug portal can guide you through the return or exchange process.
References
(KPA News, Korea), “Guju Pharm Recalls ‘Geulimideu-jeong 2mg’ Over Contamination Concerns” (구주제약 ‘글리미드정2mg’ 회수…이물 혼입 우려), 2026. Link
(Ministry of Food and Drug Safety, Korea), “Nedrug Recall & Disposal Notices” (의약품안전나라 회수·폐기 공고). Link
(Mayo Clinic), “Glimepiride (Oral Route),” 2026. Link
This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a qualified healthcare provider if you have health concerns.
Leave a Reply